The members of the Commission have evaluated that the studies available so far indicate that the traffic semaglutado is a continuous drug
Summary
The National Commission for the incorporation of technologies in Sus has decided not to include the traffic light and liraglutide in the unified health system due to high costs and effectiveness questioned in the cases analyzed.
The National Commission for the incorporation of technologies in the Unified Health System (CONITEC) did not approve the incorporation of traffic lights in the Unified Health System (Sus) to treat grade II and III obesity, without diabetes, aged between 45 years and with established cardiovascular diseases. The substance is present in the famous injectable and injectable injectable pens, which operate in the control of blood sugar, reduces the appetite and, consequently, the weight.
Receive the main news directly on WhatsApp! Sign up for the Earth channel
The Commission decision was made during a meeting on Wednesday 20 years. In the topics indicated by the negative to incorporate the Sumaglute is the high cost of the drug. To be possible to offer it financially, it would be necessary to limit access to the patients described above and for a period of only two years. This generated questions about the effectiveness of the offer.
The members of the Commission have evaluated that the studies available so far indicate that the traffic lights is a continuous drug and that there is evidence that about 33% does not maintain weight after the treatment stop.
In addition to the semaglutado, CONITEC has assessed the incorporation of the Ligutide for the treatment of patients with obesity and type 2 diabetes and adsorbed vaccine with acellular hexaval vaccine (DTAP/HB/VIP/HIB) for children up to 6 years, 11 months and 29 days of immunosopos, with special clinical conditions or increased adverse events or active events. In both cases, the recommendation was for non -incorporation in the Sus.
Liraglutide, as well as the traffic light, also has the side effect of weight loss. It is present in the injectable pen.
Source: Terra
Ben Stock is a lifestyle journalist and author at Gossipify. He writes about topics such as health, wellness, travel, food and home decor. He provides practical advice and inspiration to improve well-being, keeps readers up to date with latest lifestyle news and trends, known for his engaging writing style, in-depth analysis and unique perspectives.
